Loading
companiesCompany
Lee's Pharmaceutical
Lee's Pharmaceutical is a Hong Kong-listed company that licenses and develops medicines for Greater China, including cancer drugs it takes through phase 3 trials as lead sponsor.
Also called: Lee's Pharmaceutical LimitedLee's Pharmaceutical HoldingsLee's Pharm
Overview
Lee's Pharmaceutical Holdings, headquartered in Hong Kong and listed there, in-licenses and develops medicines for mainland China, Hong Kong and Taiwan across cardiovascular, women's health and oncology. It is lead sponsor of several phase 3 cancer trials registered on ClinicalTrials.gov.
Headquarters
Hong Kong, HK
Scorecard
All companies#379of 1244 companies, score 10
- phase 3 +3
- targets +2
- modalities +2
- registry trials +3
0 approved, 1 in phase 3, 0 earlier, 1 targets, 2 registry studies. Formula on the scorecards page.
Type
Stage
Large private
Website
Phase 3Anti-PD-L1 monoclonal antibody, intravenous
Socazolimab is Lee's Pharmaceutical's PD-L1 antibody, in phase 3 trials in China for extensive-stage small cell lung cancer and recurrent cervical cancer.
Similar pages
- CompanyPregLem
- CompanyAgennix
- CompanyLisata Therapeutics
- CompanyImmunitor
- CompanyEmergent BioSolutions
- CompanyHarbour BioMed
- CompanyCyclacel Pharmaceuticals
- CompanyVion Pharmaceuticals
drugs
Phase 3Anti-PD-L1 monoclonal antibody, intravenous